MPS Loria Financial Planners’s CorMedix CRMD Stock Holding History

MPS Loria Financial Planners’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-408	Closed	-$1K	–	139
2017 Q2	$1K	Buy	+408	New	+$1.4K	﹤0.01%	367

Other funds holding CRMD

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

MPS Loria Financial Planners's CRMD Position: Q3 2017 in Review

MPS Loria Financial Planners sold out of CorMedix (CRMD) in Q3 2017, closing a stake of 408 shares — an estimated $1K sold.

MPS Loria Financial Planners first reported a position in CRMD in Q2 2017 and held it in 1 quarter. The position peaked at $1K in Q2 2017. 33 funds tracked by Wall St. Rank hold CRMD as of Q3 2017.

MPS Loria Financial Planners reported no remaining CorMedix position as of Q3 2017 after selling out during the quarter.
MPS Loria Financial Planners sold 408 CorMedix shares in Q3 2017, an estimated $1K.
MPS Loria Financial Planners first reported a position in CorMedix in Q2 2017 and held it in 1 quarter.
MPS Loria Financial Planners's CorMedix position peaked at $1K in Q2 2017.
33 funds tracked by Wall St. Rank held CorMedix as of Q3 2017.

Based on MPS Loria Financial Planners's 13F filing for Q3 2017, filed 24 Oct 2017.